MedTrace Logo

Comparison Between Three Types of Stented Pericardial Aortic Valves

NCT01522352 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2013-09-04

No results posted yet for this study

Summary

This study suggests for the first time a comparison of the hemodynamic performance of the two most implanted aortic bioprosthesis in France with the new aortic bioprosthesis available since September 2010 at the University Hospital of Clermont Ferrand.

Conditions

  • Aortic Valve Replacement

Interventions

PROCEDURE

Aortic valve replacement by bioprosthesis

Comparison of short and mid-term hemodynamic performance between three types of stented pericardial aortic valves: Trifecta aortic valve (St. Jude Medical), Mitroflow aortic valve (Sorin Group), Magna Ease (Edwards Lifesciences)

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Sorin group, Italy

    collaborator UNKNOWN

  • Ministry of Health, France

    collaborator OTHER_GOV

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Kasra AZARNOUSH, MD, PhD · University Hospital, Clermont-Ferrand

Study Design

Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01522352 on ClinicalTrials.gov